Search research articles
Contact Us
Filters
Showing results (61-70 of 173) with videos related to
Page
of 18
Sort By:
Lancet (London, England)
|
February 9, 1985
Amiodarone in testis and semen
P C Adams, P Holt, D W Holt
Hepatology (Baltimore, Md.)
|
January 1, 1994
Hepatic iron and zinc concentrations after portacaval shunting for nonalcoholic cirrhosis
P C Adams, C Bradley, J V Frei
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
February 1, 1991
Hepatic zinc in hemochromatosis
P C Adams, C Bradley, J V Frei
The British Journal of Radiology
|
July 1, 1984
Long-term amiodarone therapy: a cause of increased hepatic attenuation on CT
D Patrick, F E White, P C Adams
Gastroenterology
|
August 1, 1991
Long-term survival analysis in hereditary hemochromatosis
P C Adams, M Speechley, A E Kertesz
The Journal of Laboratory and Clinical Medicine
|
December 9, 1997
Evaluation of the hepatic iron index as a diagnostic criterion for genetic hemochromatosis
P C Adams, C Bradley, A R Henderson
The American Journal of Medicine
|
April 1, 1991
Clinical presentation of hemochromatosis: a changing scene
P C Adams, A E Kertesz, L S Valberg
British Journal of Clinical Practice. Supplement
|
April 1, 1986
Hepatic effects of amiodarone
P C Adams, M K Bennett, D W Holt
Digestive Diseases and Sciences
|
July 1, 1995
Non-HLA-linked hemochromatosis in a Chinese woman
M Oliver, L Scully, C Guiraudon, et al.
Journal of Clinical Gastroenterology
|
April 1, 1993
Rate of iron reaccumulation following iron depletion in hereditary hemochromatosis. Implications for venesection therapy
P C Adams, A E Kertesz, L S Valberg
Page
of 18
Search research articles
Search
Showing results (61-70 of 173) with videos related to
Sort By:
Page
of 18
Lancet (London, England)
|
February 9, 1985
Amiodarone in testis and semen
P C Adams, P Holt, D W Holt
Hepatology (Baltimore, Md.)
|
January 1, 1994
Hepatic iron and zinc concentrations after portacaval shunting for nonalcoholic cirrhosis
P C Adams, C Bradley, J V Frei
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
February 1, 1991
Hepatic zinc in hemochromatosis
P C Adams, C Bradley, J V Frei
The British Journal of Radiology
|
July 1, 1984
Long-term amiodarone therapy: a cause of increased hepatic attenuation on CT
D Patrick, F E White, P C Adams
Gastroenterology
|
August 1, 1991
Long-term survival analysis in hereditary hemochromatosis
P C Adams, M Speechley, A E Kertesz
The Journal of Laboratory and Clinical Medicine
|
December 9, 1997
Evaluation of the hepatic iron index as a diagnostic criterion for genetic hemochromatosis
P C Adams, C Bradley, A R Henderson
The American Journal of Medicine
|
April 1, 1991
Clinical presentation of hemochromatosis: a changing scene
P C Adams, A E Kertesz, L S Valberg
British Journal of Clinical Practice. Supplement
|
April 1, 1986
Hepatic effects of amiodarone
P C Adams, M K Bennett, D W Holt
Digestive Diseases and Sciences
|
July 1, 1995
Non-HLA-linked hemochromatosis in a Chinese woman
M Oliver, L Scully, C Guiraudon, et al.
Journal of Clinical Gastroenterology
|
April 1, 1993
Rate of iron reaccumulation following iron depletion in hereditary hemochromatosis. Implications for venesection therapy
P C Adams, A E Kertesz, L S Valberg
Page
of 18